Jodi Ungrodt - 06 Aug 2026 Form 3 Insider Report for BioStem Technologies, Inc. (BSEM)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
14 Aug 2026, 19:12:07 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jodi Ungrodt

Key filing fact

Jodi Ungrodt filed Form 3 for BioStem Technologies, Inc. (BSEM) on 14 Aug 2026.

Key facts

  • This page summarizes Jodi Ungrodt's Form 3 filing for BioStem Technologies, Inc. (BSEM).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Aug 2026, 19:12.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002147392 Primary reporting owner

UNGRODT JODI

Relationship
Director
Address
C/O BIOSTEM TECHNOLOGIES, INC., 2836 CENTER PORT CIRCLE, POMPANO BEACH
Signature
/s/ Jodi Ungrodt
Signature date
14 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSEM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,648
Date
06 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSEM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
06 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,647
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These restricted stock units vest in two installments. The first installment vested on May 27, 2026 and the remaining installment vests on August 27, 2026.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .